Skip to main content
. 2022 Nov 26;22:879. doi: 10.1186/s12884-022-05211-y

Table 2.

Patients in different degree of TBA level

TBA No PE EOPE LOPE Mild PE Severe PE
No. (%) p valuea OR (95% CI) No. (%) p valuea OR (95% CI)a No. (%) p valuea OR (95% CI)a No. (%) p valueb OR (95% CI) No. (%) p valueb OR (95% CI)
 < 1.6 865 270 (31.25) 1(reference) 112(12.95) 1(reference) 158(18.27) 1(reference) 147 (54.44) 1(reference) 123 (45.56) 1(reference)
1.6 to < 4.1 1322 545 (41.26)  < 0.001 1.82(1.47–2.26) 241(18.23) 0.001 1.62(1.23–2.12) 304(23.0) 0.002 1.45(1.15–1.82) 237 (43.49) 0.002 0.61(0.45–0.83) 308 (56.51) 0.002 1.64(1.2–2.24)
4.1 to < 8.2 361 192 (53.33)  < 0.001 2.37(1.71–3.28) 93(25.76) 0.001 1.93(1.33–2.81) 99(27.42) 0.004 1.63(1.17–2.28) 74 (38.54) 0.005 0.56(0.38–0.84) 118 (61.46) 0.005 1.78(1.19–2.66)
8.2 to < 10 37 23 (63.89) 0.001 4.63(1.89–11.35) 10(27.03) 0.011 3.46(1.32–9.04) 13(35.14) 0.003 3.75(1.57–8.98) 5 (21.74) 0.007 0.23(0.08–0.67) 18 (78.26) 0.007 4.27(1.48–12.3)

Adjustment for AST, ALT, T bilirubin, TC, TG, ALB, pregestational diabetes, nulliparity and IVF

PE preeclampsia, EOPE early-onset PE, LOPE late-onset PE

aCompared PE patients with non-PE patients in total pregnant women

bCompared mild PE or severe PE with all PE patients